Purchase Order 75N92C19P00065
Award Date 9/12/19
Potential Completion Date 11/29/19
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Advanced Cell Diagnostics, Inc. (ACD) has been awarded a $26,945 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NIH NINDS) to provide RNAScope HiPlex Probes and Reagents. The solicitation sought these specific products from ACD to support research at NIH NINDS aimed at identifying and quantifying 40 RNA molecules in mouse brain tissue using ACD's proprietary RNAScope assay method. Delivery within one week of order...
- This is a firm-fixed-price purchase order contract awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency under the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract, valued at $25,000.00, is for the provision of ACD's proprietary RNAscope reagent kits and custom RNA probes, which enable the precise visualization and quantification of RNA biomarkers. This contract...
- This firm-fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The $20,000.00 contract supports ACD's provision of its proprietary RNAscope reagents, kits, probes, and related services to aid various biomedical research efforts across NIH and its institutes, including the National Cancer Institute, National Institute of...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $18,690.00 contract provides ACD's proprietary RNAscope assay biological products, including kits, reagents, and probes, to support various biomedical research efforts across NIH. These products enable the visualization and...
- This federal contract awards $34,976.00 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics, to provide the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases with various RNAscope kits and reagents. The contract is a firm-fixed-price purchase order with no set-aside designation. ACD, a subsidiary of Bio-Techne Corporation, has a strong track record of providing these types of...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD) for the delivery of reagent kits. The contract has a ceiling value of $5,042.00 and an ultimate completion date of December 21, 2015. ACD is a molecular diagnostics company specializing in RNA detection technologies, and its proprietary RNAscope technology has been utilized in...
- This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $10,488.08 contract is for the provision of ACD's proprietary RNAscope technology and related products, which enable the visualization and quantification of RNA biomarkers. This contract supports biomedical research efforts across various National Institutes of...
- This $4,960 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company that specializes in RNA detection technologies. The contract is for the provision of reagent kits, which ACD supplies to support biomedical research efforts across various National Institutes of Health (NIH) institutes and other federal agencies. ACD's proprietary RNAscope technology and related...
- This is a $20,000.00 firm-fixed-price purchase order contract awarded to Advanced Cell Diagnostics, Inc. (ACD) by the National Institute on Drug Abuse, a component of the National Institutes of Health (NIH). The contract is for the delivery of ACD's proprietary RNAscope reagent kits and probes for research applications. ACD, a subsidiary of Bio-Techne Corporation, is a leading provider of molecular diagnostic tools and has been awarded over 50 prime federal contracts, primarily from NIH and...
- The federal contract award HHSN272201500399P was granted to Advanced Cell Diagnostics, Inc. (ACD) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $3,790 firm-fixed-price purchase order is for the provision of reagent kits and probes, with no set-aside designation. ACD is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. The company has...
Advanced Cell Diagnostics, Inc. (ACD) has been awarded a firm fixed price purchase order valued at fifteen thousand and forty dollars ($15,040) from the National Institutes of Health's National Institute of Dental and Craniofacial Research. The contract is for ACD to provide its proprietary RNAScope MFV2 in-house assay project service fee and accompanying reagent kits and control/marker probe costs. ACD will deliver the requested products and services in support of molecular pathology research being conducted by the funding agency. No set aside designation was applied to this award. ACD is a leader in molecular diagnostic tools and services and has over fifty previous federal contracts with agencies such as NIH, VA, USDA, and CDC.
Generated 3/15/24, 11:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($600) | 3/14/24 | |
| P00001 | Other Administrative Action | $0 | 9/12/19 | |
| Not listed | Not listed | $15.6k | 9/12/19 |